Acceleration in HIV-vaccine Development Might Be Achieved Recently
A new technique of HIV-sorting, developed by European Molecular Biology Laboratory (EMBL) gives a hope to the scientists that HIV-vaccine can be discovered faster than expected.
There are some lucky HIV-positive patients (about 1%), also called as elite controllers, their immune systems produce specific proteins. That kind of proteins can switch off the activity of the HIV-virus. Scientists hope to find all the details that make proteins so particular and unique, and later to elicit a response similar to that seen in elite controllers.
Analysis and selection of different types of HIV are possible now, thanks to the method as mentioned earlier. The method makes all the process of viruses testing faster, which is expected to speed up the development of HIV-vaccine in future.
European Molecular Biology Laboratory (EMBL). "Sorting out HIV: Research collaboration devises a new method that could speed up vaccine development for HIV."